Year |
Citation |
Score |
2021 |
Sun J, Uchiyama S, Olson J, Morodomi Y, Cornax I, Ando N, Kohno Y, Kyaw MMT, Aguilar B, Haste NM, Kanaji S, Kanaji T, Rose WE, Sakoulas G, Marth JD, et al. Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear bacteremia. Science Translational Medicine. 13. PMID 33762439 DOI: 10.1126/scitranslmed.abd6737 |
0.41 |
|
2017 |
Guichard A, Jain P, Moayeri M, Schwartz R, Chin S, Zhu L, Cruz-Moreno B, Liu JZ, Aguilar B, Hollands A, Leppla SH, Nizet V, Bier E. Anthrax edema toxin disrupts distinct steps in Rab11-dependent junctional transport. Plos Pathogens. 13: e1006603. PMID 28945820 DOI: 10.1371/Journal.Ppat.1006603 |
0.602 |
|
2015 |
Grimsey NJ, Aguilar B, Smith TH, Le P, Soohoo AL, Puthenveedu MA, Nizet V, Trejo J. Ubiquitin plays an atypical role in GPCR-induced p38 MAP kinase activation on endosomes. The Journal of Cell Biology. PMID 26391660 DOI: 10.1083/Jcb.201504007 |
0.445 |
|
2014 |
Fair RJ, McCoy LS, Hensler ME, Aguilar B, Nizet V, Tor Y. Singly modified amikacin and tobramycin derivatives show increased rRNA A-site binding and higher potency against resistant bacteria. Chemmedchem. 9: 2164-71. PMID 25055981 DOI: 10.1002/Cmdc.201402175 |
0.647 |
|
2013 |
Guichard A, Cruz-Moreno B, Cruz-Moreno BC, Aguilar B, van Sorge NM, Kuang J, Kurkciyan AA, Wang Z, Hang S, Pineton de Chambrun GP, McCole DF, Watnick P, Nizet V, Bier E. Cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. Cell Host & Microbe. 14: 294-305. PMID 24034615 DOI: 10.1016/J.Chom.2013.08.001 |
0.647 |
|
Show low-probability matches. |